BioSenic S.A. (BIOS) — Cash Flow-to-Debt Ratio
BioSenic S.A. (BIOS) has a Cash Flow-to-Debt Ratio of -0.04x as of December 2024, meaning its operating cash flow of €-1.39 Million could theoretically repay 0% of its total liabilities (€31.55 Million) in one year. See BioSenic S.A. (BIOS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BioSenic S.A. Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for BioSenic S.A. across 13 annual periods. Also explore BioSenic S.A. net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BioSenic S.A. (2012–2024)
Year-by-year debt coverage analysis for BioSenic S.A.. For market capitalisation and broader financial context, see BIOS market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.07x | €-2.23 Million | €31.55 Million | ▲ +34.2% |
| 2023 | -0.11x | €-3.47 Million | €32.26 Million | ▼ -47.5% |
| 2022 | -0.07x | €-1.91 Million | €26.20 Million | ▲ +84.9% |
| 2021 | -0.48x | €-12.78 Million | €26.54 Million | ▲ +35.6% |
| 2020 | -0.75x | €-16.08 Million | €21.51 Million | ▼ -46.3% |
| 2019 | -0.51x | €-10.40 Million | €20.34 Million | ▲ +15.8% |
| 2018 | -0.61x | €-12.90 Million | €21.26 Million | ▼ -25.5% |
| 2017 | -0.48x | €-11.02 Million | €22.79 Million | ▲ +0.9% |
| 2016 | -0.49x | €-11.37 Million | €23.32 Million | ▲ +7.8% |
| 2015 | -0.53x | €-11.77 Million | €22.24 Million | ▼ -405.8% |
| 2014 | -0.10x | €-3.52 Million | €33.69 Million | ▲ +59.3% |
| 2013 | -0.26x | €-3.27 Million | €12.75 Million | ▲ +25.3% |
| 2012 | -0.34x | €-4.05 Million | €11.78 Million | — |